WASHINGTON (Reuters) - Two biotech drugs used to treat rheumatoid arthritis -- Abbott Laboratories Inc.'s Humira and Johnson & Johnson’s Remicade -- may raise the risk of cancer and infections but not as much as was feared, researchers said on Tuesday.>>> Discuss This Story
